Inventiva S.A. (EPA:IVA)
3.450
-0.075 (-2.13%)
Dec 5, 2025, 5:36 PM CET
Inventiva Revenue
Inventiva had revenue of 2.81M EUR in the half year ending June 30, 2025, with 105.19% growth. This brings the company's revenue in the last twelve months to 12.07M, down -11.15% year-over-year. In the year 2024, Inventiva had annual revenue of 14.72M, down -36.43%.
Revenue (ttm)
12.07M
Revenue Growth
-11.15%
P/S Ratio
38.84
Revenue / Employee
202.02K
Employees
118
Market Cap
659.06M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.72M | -8.44M | -36.43% |
| Dec 31, 2023 | 23.16M | 4.35M | 23.12% |
| Dec 31, 2022 | 18.81M | 10.31M | 121.32% |
| Dec 31, 2021 | 8.50M | 3.24M | 61.52% |
| Dec 31, 2020 | 5.26M | -6.03M | -53.39% |
| Dec 31, 2019 | 11.29M | 3.91M | 53.02% |
| Dec 31, 2018 | 7.38M | -2.58M | -25.90% |
| Dec 31, 2017 | 9.96M | 512.36K | 5.42% |
| Dec 31, 2016 | 9.45M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 45.93B |
| EssilorLuxottica Société anonyme | 27.24B |
| Eurofins Scientific SE | 7.14B |
| emeis Société anonyme | 5.77B |
| Clariane SE | 5.31B |
| Ramsay Générale de Santé | 5.24B |
| bioMérieux | 4.12B |
| Ipsen | 3.76B |
Inventiva News
- 11 days ago - Inventiva S.A. reports nine-months results - Seeking Alpha
- 14 days ago - Inventiva reports 2025 Third Quarter Financial Information¹ - GlobeNewsWire
- 17 days ago - Inventiva (IVA): Guggenheim Lowers Price Target Amidst Maintained Buy Rating | IVA Stock News - GuruFocus
- 19 days ago - Inventiva announces full exercise of Underwriters' Option, bringing proceeds of Offering to approximately $172.5M - GlobeNewsWire
- 19 days ago - Wall Street Week Ahead - Seeking Alpha
- 22 days ago - Inventiva Prices Of Upsized Public Offering Of About $150 Mln ADS - Nasdaq
- 22 days ago - Inventiva announces trading resumption of its ordinary shares on Euronext Paris - GlobeNewsWire
- 22 days ago - Inventiva announces pricing of upsized public offering of approximately $150M of American Depositary Shares - GlobeNewsWire